Abstract
The glycemia risk index (GRI) is an emerging metric designed to quantify the risk of both hypo- and hyperglycemia, providing a combined assessment of glycemic control quality. A high GRI is associated with an increased risk of diabetic complications. In this study, we leverage long-term continuous glucose monitoring (CGM) data to develop and validate predictive models for a high GRI (>60) in individuals with T1D. We assessed over 250 000 days of measurements collected over four years from 736 patients with type 1 diabetes. Our modeling approach shows promise for predicting glycemic control quality (area under the receiver operating characteristic curve [ROC-AUC] of 0.87) six to nine months from baseline. However, additional analysis and validation are imperative to determine its full clinical utility.
Get full access to this article
View all access options for this article.
